Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/15/2023 | -0.73% | Morgan Stanley | $27 → $26 | Maintains | Equal-Weight |
11/07/2023 | 26% | Stifel | $45 → $33 | Maintains | Buy |
10/16/2023 | 33.64% | JP Morgan | $47 → $35 | Maintains | Overweight |
10/10/2023 | 39.37% | Citigroup | $33.93 → $36.5 | Maintains | Buy |
10/09/2023 | 3.09% | Morgan Stanley | $44 → $27 | Maintains | Equal-Weight |
10/09/2023 | 10.73% | Jefferies | $44 → $29 | Upgrades | Hold → Buy |
10/05/2023 | 10.73% | UBS | $43 → $29 | Maintains | Buy |
10/05/2023 | 6.91% | Oppenheimer | $50 → $28 | Maintains | Outperform |
09/25/2023 | 64.18% | RBC Capital | $48 → $43 | Maintains | Sector Perform |
09/14/2023 | 71.82% | Stifel | → $45 | Reiterates | Buy → Buy |
09/08/2023 | 79.46% | B of A Securities | $48 → $47 | Maintains | Buy |
09/01/2023 | 79.46% | Citigroup | $45 → $47 | Upgrades | Neutral → Buy |
08/22/2023 | 64.18% | UBS | → $43 | Upgrades | Neutral → Buy |
08/10/2023 | 45.09% | Barclays | $36 → $38 | Maintains | Underweight |
08/09/2023 | 79.46% | JP Morgan | $42 → $47 | Maintains | Overweight |
08/09/2023 | 68% | Morgan Stanley | $41 → $44 | Maintains | Equal-Weight |
07/17/2023 | 87.09% | Bernstein | → $49 | Assumes | Market Perform → Outperform |
06/01/2023 | 60.37% | UBS | → $42 | Initiates Coverage On | → Neutral |
05/10/2023 | 83.28% | RBC Capital | → $48 | Reiterates | → Sector Perform |
05/10/2023 | 56.55% | Morgan Stanley | $40 → $41 | Maintains | Equal-Weight |
04/19/2023 | 45.09% | Bernstein | → $38 | Initiates Coverage On | → Market Perform |
04/04/2023 | 60.37% | Stifel | $45 → $42 | Maintains | Buy |
03/22/2023 | 48.91% | Baird | $43 → $39 | Maintains | Neutral |
03/21/2023 | 52.73% | Morgan Stanley | $43 → $40 | Maintains | Equal-Weight |
03/20/2023 | 56.55% | JP Morgan | $44 → $41 | Maintains | Overweight |
02/08/2023 | 64.18% | Morgan Stanley | $44 → $43 | Maintains | Equal-Weight |
02/08/2023 | 83.28% | RBC Capital | → $48 | Reiterates | → Sector Perform |
02/08/2023 | 68% | JP Morgan | $45 → $44 | Maintains | Overweight |
01/27/2023 | 71.82% | Citigroup | $39 → $45 | Maintains | Neutral |
01/04/2023 | 68% | Morgan Stanley | $41 → $44 | Maintains | Equal-Weight |
12/02/2022 | 37.46% | Barclays | $34 → $36 | Maintains | Underweight |
11/16/2022 | 64.18% | Deutsche Bank | $40 → $43 | Maintains | Hold |
11/16/2022 | 56.55% | Morgan Stanley | $38 → $41 | Maintains | Equal-Weight |
11/16/2022 | 71.82% | RBC Capital | $38 → $45 | Maintains | Sector Perform |
10/25/2022 | 37.46% | Jefferies | → $36 | Assumes | → Hold |
10/13/2022 | 45.09% | RBC Capital | $41 → $38 | Maintains | Sector Perform |
09/27/2022 | 45.09% | Morgan Stanley | $37 → $38 | Maintains | Equal-Weight |
08/10/2022 | 52.73% | Deutsche Bank | $38 → $40 | Maintains | Hold |
08/10/2022 | 41.28% | Morgan Stanley | $35 → $37 | Maintains | Equal-Weight |
07/20/2022 | 33.64% | Morgan Stanley | $37 → $35 | Maintains | Equal-Weight |
05/11/2022 | 41.28% | Morgan Stanley | $38 → $37 | Maintains | Equal-Weight |
03/30/2022 | 45.09% | Deutsche Bank | → $38 | Initiates Coverage On | → Hold |
01/05/2022 | 52.73% | Morgan Stanley | $39 → $40 | Maintains | Equal-Weight |
12/10/2021 | 48.91% | Morgan Stanley | $37 → $39 | Maintains | Equal-Weight |
11/19/2021 | 52.73% | Citigroup | $35 → $40 | Maintains | Neutral |
11/02/2021 | 56.55% | RBC Capital | $38 → $41 | Maintains | Sector Perform |
10/21/2021 | 52.73% | Berenberg | $36 → $40 | Upgrades | Hold → Buy |
09/17/2021 | 22.18% | Barclays | $35 → $32 | Downgrades | Equal-Weight → Underweight |
04/13/2021 | 41.28% | Morgan Stanley | $34 → $37 | Maintains | Equal-Weight |
01/06/2021 | 29.82% | Morgan Stanley | $31 → $34 | Maintains | Equal-Weight |
11/18/2020 | 18.37% | Morgan Stanley | $26 → $31 | Maintains | Equal-Weight |
10/22/2020 | 10.73% | Citigroup | $28 → $29 | Downgrades | Buy → Neutral |
10/20/2020 | -0.73% | Morgan Stanley | $24 → $26 | Maintains | Equal-Weight |
09/25/2020 | 33.64% | Oppenheimer | $30 → $35 | Maintains | Outperform |
09/09/2020 | 37.46% | Goldman Sachs | $23 → $36 | Upgrades | Neutral → Buy |
08/24/2020 | -0.73% | Jefferies | $25 → $26 | Maintains | Hold |
08/05/2020 | -8.36% | Morgan Stanley | $25 → $24 | Maintains | Equal-Weight |
07/16/2020 | -0.73% | RBC Capital | $35 → $26 | Downgrades | Outperform → Sector Perform |
07/10/2020 | -4.54% | Morgan Stanley | $26 → $25 | Maintains | Equal-Weight |
06/25/2020 | -0.73% | Morgan Stanley | $25 → $26 | Maintains | Equal-Weight |
06/16/2020 | 10.73% | Citigroup | $30 → $29 | Maintains | Buy |
05/06/2020 | -8.36% | Baird | $25 → $24 | Maintains | Neutral |
05/06/2020 | -4.54% | Morgan Stanley | $27 → $25 | Maintains | Equal-Weight |
04/23/2020 | 3.09% | Morgan Stanley | $25 → $27 | Maintains | Equal-Weight |
04/06/2020 | 14.55% | Oppenheimer | $50 → $30 | Maintains | Outperform |
03/23/2020 | 14.55% | Citigroup | $39 → $30 | Upgrades | Sell → Buy |
03/18/2020 | -4.54% | Morgan Stanley | $47 → $25 | Maintains | Equal-Weight |
02/10/2020 | 48.91% | Citigroup | → $39 | Initiates Coverage On | → Sell |
01/17/2020 | 64.18% | Berenberg | $37 → $43 | Downgrades | Buy → Hold |
11/22/2019 | 87.09% | Jefferies | → $49 | Initiates Coverage On | → Hold |
11/20/2019 | 75.64% | Morgan Stanley | $43 → $46 | Maintains | Equal-Weight |
10/10/2019 | 64.18% | Morgan Stanley | $40 → $43 | Maintains | Equal-Weight |
09/19/2019 | 71.82% | Barclays | $35 → $45 | Maintains | Equal-Weight |
08/23/2019 | — | Oppenheimer | Initiates Coverage On | → Outperform | |
08/19/2019 | — | Nomura | Upgrades | Neutral → Buy | |
08/19/2019 | — | Stifel | Upgrades | Hold → Buy | |
08/07/2019 | — | Stifel | Downgrades | Buy → Hold | |
08/07/2019 | 52.73% | Baird | $38 → $40 | Downgrades | Outperform → Neutral |
03/18/2019 | 6.91% | Nomura | $46 → $28 | Downgrades | Buy → Neutral |
02/11/2019 | — | Goldman Sachs | Downgrades | Buy → Neutral | |
01/17/2019 | — | Berenberg | Upgrades | Hold → Buy | |
12/12/2018 | 68% | JP Morgan | $48 → $44 | Maintains | Overweight |
12/12/2018 | 48.91% | Baird | $44 → $39 | Maintains | Outperform |
11/20/2018 | 79.46% | RBC Capital | → $47 | Initiates Coverage On | → Outperform |
11/15/2018 | 79.46% | Nomura | $50 → $47 | Maintains | Buy |
What is the target price for Aramark (ARMK)?
The latest price target for Aramark (NYSE: ARMK) was reported by Morgan Stanley on November 15, 2023. The analyst firm set a price target for $26.00 expecting ARMK to fall to within 12 months (a possible -0.73% downside). 34 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aramark (ARMK)?
The latest analyst rating for Aramark (NYSE: ARMK) was provided by Morgan Stanley, and Aramark maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Aramark (ARMK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aramark, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aramark was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.
Is the Analyst Rating Aramark (ARMK) correct?
While ratings are subjective and will change, the latest Aramark (ARMK) rating was a maintained with a price target of $27.00 to $26.00. The current price Aramark (ARMK) is trading at is $26.19, which is out of the analyst's predicted range.